Pyxis Oncology, Inc. (PYXS)
Nasdaq: PYXS · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2019
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 23, 2026 | Mar 18, 2025 | Mar 21, 2024 | Mar 22, 2023 | Mar 29, 2022 | · |
| Revenue | 13,858 | 16,146 | · | · | · | · |
| Cost of revenue | 2,388 | 475 | · | · | · | · |
| Research and development | 73,696 | 58,747 | 49,586 | 86,129 | 51,054 | 9,048 |
| General and administrative | 22,194 | 25,420 | 32,610 | 37,352 | 18,663 | 3,846 |
| Total operating expenses | · | · | 82,196 | 123,481 | 69,717 | 12,894 |
| Operating income | -84,420 | -89,460 | -82,196 | -123,481 | -69,717 | -12,894 |
| Interest and investment income | 650 | 930 | 1,842 | 2,764 | 23 | 66 |
| Share of profit of equity-method investments | · | · | · | 0 | -231 | · |
| Total non-operating income (expense) | 6,185 | 9,965 | 8,406 | 2,764 | -6,027 | 66 |
| Income before income taxes | -78,235 | -79,495 | -73,790 | · | · | · |
| Income tax expense | 1,386 | -2,164 | · | · | · | · |
| Net income including non-controlling interests | -79,621 | -77,331 | -73,790 | -120,717 | -75,975 | -12,828 |
| Net income | -79,621 | -77,331 | -73,790 | -120,717 | -75,975 | -12,828 |
| Earnings per share, basic | -1.28 | -1.32 | -1.85 | -3.65 | -8.95 | · |
| Earnings per share, diluted | -1.28 | -1.32 | -1.85 | -3.65 | -8.95 | · |
| Earnings per share, basic and diluted | · | · | · | · | -8.95 | -12.45 |
| Weighted average shares, basic | 62,143,166 | 58,445,765 | 39,904,603 | 33,033,081 | 8,493,273 | · |
| Weighted average shares, diluted | 62,143,166 | 58,445,765 | 39,904,603 | 33,033,081 | 8,493,273 | · |
| Weighted average shares, basic and diluted | · | · | · | · | 8,493,273 | 1,030,556 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestShare of profit of equity-method investments its share of companies it partly owns
us-gaap:IncomeLossFromEquityMethodInvestmentsTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted